10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 254 filers reported holding 10X GENOMICS INC in Q3 2023. The put-call ratio across all filers is 0.48 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $522,019 | -33.1% | 12,655 | -9.4% | 0.32% | +0.6% |
| Q2 2023 | $780,085 | -1.0% | 13,970 | -1.1% | 0.32% | -31.4% |
| Q1 2023 | $787,699 | +57.4% | 14,119 | +2.8% | 0.47% | +38.5% |
| Q4 2022 | $500,503 | +22.7% | 13,735 | -4.1% | 0.34% | -4.0% |
| Q3 2022 | $408,000 | -32.8% | 14,315 | +6.8% | 0.35% | -1.9% |
| Q2 2022 | $607,000 | -40.7% | 13,409 | -0.3% | 0.36% | -1.4% |
| Q1 2022 | $1,023,000 | -5.5% | 13,444 | +85.1% | 0.37% | +5.5% |
| Q4 2021 | $1,082,000 | – | 7,264 | – | 0.35% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 962,309 | $188,439,000 | 95.08% |
| Foresite Capital Management II, LLC | 1,753,528 | $343,376,000 | 92.37% |
| Foresite Capital Management I, LLC | 750,000 | $146,865,000 | 88.53% |
| 12 West Capital Management LP | 1,922,000 | $376,366,000 | 15.78% |
| Financial Consulate Inc. | 141,258 | $27,661,000 | 9.97% |
| FINANCIAL CONSULATE, INC | 141,258 | $27,661,000 | 9.97% |
| Meritech Capital Associates V L.L.C. | 1,793,871 | $351,276,000 | 7.51% |
| Andar Capital Management HK Ltd | 51,000 | $9,987,000 | 6.81% |
| JS Capital Management LLC | 540,589 | $105,858,000 | 5.12% |
| Renaissance Capital LLC | 97,281 | $19,050,000 | 3.01% |